Clinical Trial Update: Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome [Phase 4]

View source ↗

Summary

Clinical trial evaluating atorvastatin for dyslipidemia in children with steroid-sensitive nephrotic syndrome; Phase 4 study now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Steroid-sensitive Nephrotic Syndrome

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: National Institute of Kidney Disease and Urology (NIKDU) | Conditions: Dyslipidaemia | Phase 4 | Status: COMPLETED